These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 20522140)
1. The skinny on fat. Goldie MP Int J Dent Hyg; 2010 May; 8(2):150-2. PubMed ID: 20522140 [No Abstract] [Full Text] [Related]
2. [Weight reduction. Antiobesity drug treatment in type-2 diabetics]. Verspohl EJ Pharm Unserer Zeit; 2002; 31(3):300-7. PubMed ID: 12071127 [No Abstract] [Full Text] [Related]
3. New therapeutic tool in diabetes management. Community Nurse; 2000 Dec; 6(11):6. PubMed ID: 11982176 [No Abstract] [Full Text] [Related]
4. [Pharmacotherapy for weight loss in patients with type 2 diabetes]. Toubro S Ugeskr Laeger; 2007 Aug; 169(33):2619-22. PubMed ID: 17725907 [No Abstract] [Full Text] [Related]
5. Prevention of high-fat diet-induced adipose tissue remodeling in obese diabetic mice by n-3 polyunsaturated fatty acids. Huber J; Löffler M; Bilban M; Reimers M; Kadl A; Todoric J; Zeyda M; Geyeregger R; Schreiner M; Weichhart T; Leitinger N; Waldhäusl W; Stulnig TM Int J Obes (Lond); 2007 Jun; 31(6):1004-13. PubMed ID: 17130847 [TBL] [Abstract][Full Text] [Related]
6. [Xenical--a modern perspective drug for the treatment of obesity (review)]. Mkrtumian AM; Biriukova EV Ter Arkh; 2007; 79(10):35-9. PubMed ID: 18154143 [No Abstract] [Full Text] [Related]
8. The success of bariatric surgery as treatment of type 2 diabetes should be a call to revitalize anti-obesity drug discovery and development. Opgenorth TJ Curr Opin Investig Drugs; 2008 Apr; 9(4):355-6. PubMed ID: 18393101 [No Abstract] [Full Text] [Related]
12. Orlistat in the treatment of NASH: a case series. Harrison SA; Ramrakhiani S; Brunt EM; Anbari MA; Cortese C; Bacon BR Am J Gastroenterol; 2003 Apr; 98(4):926-30. PubMed ID: 12738478 [TBL] [Abstract][Full Text] [Related]
13. [Hepatocellular carcinoma and non alcoholic steatohepatitis: are we looking at the tip of the iceberg?]. Ratziu V; Le Calvez S; Bonyhay L; Taieb J; Poynard T Gastroenterol Clin Biol; 2003 Oct; 27(10):869-75. PubMed ID: 14631300 [No Abstract] [Full Text] [Related]
18. Obesity and diabetes as a risk factor for hepatocellular carcinoma. Regimbeau JM; Colombat M; Mognol P; Durand F; Abdalla E; Degott C; Degos F; Farges O; Belghiti J Liver Transpl; 2004 Feb; 10(2 Suppl 1):S69-73. PubMed ID: 14762843 [TBL] [Abstract][Full Text] [Related]
19. Fat pill for teens. Xenical may have the FDA's blessing, but is it a good idea? Gupta S Time; 2003 Dec 29-2004 Jan 5; 162(26):162. PubMed ID: 14722944 [No Abstract] [Full Text] [Related]
20. Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients. Derosa G; Cicero AF; Murdolo G; Ciccarelli L; Fogari R Diabetes Nutr Metab; 2004 Aug; 17(4):222-9. PubMed ID: 15575343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]